Insider Trading Alert - NCMI, GGP And ARTX Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Yesterday, June 18, 2015, 71 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $77.50 to $28,170,000.00.

Highlighted Stocks Traded by Insiders:

National CineMedia (NCMI) - FREE Research Report

Madison Paula Williams, who is Director at National CineMedia, sold 5,144 shares at $16.23 on June 18, 2015. Following this transaction, the Director owned 0 shares meaning that the stake was reduced by 100% with the 5,144-share transaction.

The shares most recently traded at $16.58, up $0.35, or 2.09% since the insider transaction. Historical insider transactions for National CineMedia go as follows:

  • 4-Week # shares sold: 9,461
  • 12-Week # shares sold: 9,461
  • 24-Week # shares sold: 9,461

The average volume for National CineMedia has been 268,100 shares per day over the past 30 days. National CineMedia has a market cap of $1.0 billion and is part of the services sector and media industry. Shares are up 13.36% year-to-date as of the close of trading on Thursday.

National CineMedia, Inc., together with its subsidiaries, operates a digital in-theatre media network in North America. The stock currently has a dividend yield of 5.4%. The company has a P/E ratio of 135.8. Currently, there are 8 analysts who rate National CineMedia a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on NCMI - FREE

TheStreet Quant Ratings rates National CineMedia as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself, deteriorating net income and weak operating cash flow. Get the full National CineMedia Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

General Growth Properties (GGP) - FREE Research Report

Marszewski Tara, who is SVP, Chief Accounting Officer at General Growth Properties, sold 757 shares at $27.63 on June 18, 2015. Following this transaction, the SVP, Chief Accounting Officer owned 2,573 shares meaning that the stake was reduced by 22.73% with the 757-share transaction.

The shares most recently traded at $27.53, down $0.10, or 0.37% since the insider transaction. Historical insider transactions for General Growth Properties go as follows:

  • 4-Week # shares bought: 3,400
  • 4-Week # shares sold: 323,450
  • 12-Week # shares bought: 3,400
  • 12-Week # shares sold: 323,450
  • 24-Week # shares bought: 3,400
  • 24-Week # shares sold: 11.9 million

The average volume for General Growth Properties has been 4.1 million shares per day over the past 30 days. General Growth Properties has a market cap of $24.0 billion and is part of the financial sector and real estate industry. Shares are down 3.7% year-to-date as of the close of trading on Thursday.

General Growth Properties, Inc is an equity real estate investment trust. The firm invests in the real estate markets of the United States. It engages in owning, managing, leasing, and redeveloping high-quality regional malls. General Growth Properties, Inc is based in Chicago, Illinois. The stock currently has a dividend yield of 2.51%. The company has a P/E ratio of 22.6. Currently, there are 10 analysts who rate General Growth Properties a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on GGP - FREE

TheStreet Quant Ratings rates General Growth Properties as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth, compelling growth in net income, expanding profit margins and notable return on equity. We feel its strengths outweigh the fact that the company shows weak operating cash flow. Get the full General Growth Properties Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Arotech (ARTX) - FREE Research Report

Esses Steven D, who is President and CEO at Arotech, sold 300 shares at $3.01 on June 18, 2015. Following this transaction, the President and CEO owned 1.2 million shares meaning that the stake was reduced by 0.03% with the 300-share transaction.

The shares most recently traded at $2.62, down $0.39, or 15.01% since the insider transaction. Historical insider transactions for Arotech go as follows:

  • 4-Week # shares bought: 7,500
  • 4-Week # shares sold: 5,000
  • 12-Week # shares bought: 7,500
  • 12-Week # shares sold: 5,000
  • 24-Week # shares bought: 7,500
  • 24-Week # shares sold: 25,000

The average volume for Arotech has been 172,800 shares per day over the past 30 days. Arotech has a market cap of $66.6 million and is part of the industrial goods sector and industrial industry. Shares are up 16.38% year-to-date as of the close of trading on Thursday.

Arotech Corporation, through its subsidiaries, provides defense and security products in the United States, Israel, Saudi Arabia, Korea, Germany, Canada, the United Arab Emirates, Australia, China, Hong Kong, India, Mexico, and internationally. The company has a P/E ratio of 30.0. Currently, there is 1 analyst who rates Arotech a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ARTX - FREE

TheStreet Quant Ratings rates Arotech as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth and largely solid financial position with reasonable debt levels by most measures. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and poor profit margins. Get the full Arotech Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

If you liked this article you might like

3 High-Yield Dividend Stocks to Avoid

3 High-Yield Dividend Stocks to Avoid

Insider Trading Alert - NCMI, ERI And CFFI Traded By Insiders

Insider Trading Alert - NCMI, ERI And CFFI Traded By Insiders

AMC Inks $1.1 Billion Blockbuster Deal for Carmike

AMC Inks $1.1 Billion Blockbuster Deal for Carmike

Insider Trading Alert - MACK, CASH And NCMI Traded By Insiders

Insider Trading Alert - MACK, CASH And NCMI Traded By Insiders

Insider Trading Alert - NCMI, RE And PCLN Traded By Insiders

Insider Trading Alert - NCMI, RE And PCLN Traded By Insiders